Risk factors for COVID-19 vaccine failure.

• Conditions: U07.1; K50; K51; K52; COVID-19, virus identified; Crohn disease [regional enteritis]; Ulcerative colitis; Other noninfective gastroenteritis and colitis

• Registration Number: DRKS00026804
• Lead Sponsor: Klinikum der Universität München, Campus Großhadern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-06
• Results First Posted: 2023-09-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 4373

Inclusion Criteria

Fully vaccinated against COVID-19 (one or two vaccinations depending on manufacturer), male, female, diverse.
- Age: > 18 years, for CED patients >12 years
- Sufficient knowledge of the German language
- Internet access for online-supported survey
- Signed informed consent to participate in the study (for minors additionally of the persons with custody)
- Belonging to one of the three groups
- Employees of the LMU University Hospital, or trainees/students/interns at the hospital
- Patients with chronic inflammatory bowel diseases with immunosuppressive therapy with connection to CED outpatient clinic at LMU University Hospital
- Patients with mental illnesses without immunosuppressive therapy with connection to the Psychiatric Clinic at LMU University Hospital

Exclusion Criteria

- Inclusion criteria not met
- Psychiatric illness with recent (within the past year) or active suicidal ideation or behaviors/other reasons that may make the potential participant unsuitable for the study in the opinion of the investigator(s).
- Individuals who have received blood or plasma products or immunoglobulins in the 60 days prior to the study.

Study & Design

• Study Type: observational
• Study Design: Not specified